retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
['breast']
briacell presents positive data demonstrating survival and clinical benefits in advanced metastatic breast cancer at the 2023 aacr 
CoreIR provides strategic investor and public relations services for small-mid cap companies. Experience the difference. #investorrelations #publicrelations